Aegeria Soft Tissue Overview

  • Founded
  • 2009
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Investors
  • 1

Aegeria Soft Tissue General Information


Developer of tissue reconstruction technologies. The company develops tissue reconstruction technologies that provides a natural structure to mimic normal soft tissue and promote new fat tissue growth.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 7 Street, Paul Street
  • Suite 1660
  • Baltimore, MD 21202
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aegeria Soft Tissue Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 01-Oct-2011 Completed Startup
1. Accelerator/Incubator 01-Jan-2011 Completed Startup
To view Aegeria Soft Tissue’s complete valuation and funding history, request access »

Aegeria Soft Tissue Executive Team (4)

Name Title Board Seat Contact Info
Alessandro Ovi Co-Founder
Jennifer Elisseeff Ph.D Co-Founder
Lee Marks Co-Founder
Patrick Byrne MD Chief Medical Officer
To view Aegeria Soft Tissue’s complete executive team members history, request access »

Aegeria Soft Tissue Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Aegeria Soft Tissue’s complete investors history, request access »